Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep-Oct;7(5):1002-1006.
doi: 10.4103/jfmpc.jfmpc_75_16.

Economic impact of chronic obstructive pulmonary disease: A cross-sectional study at teaching hospital in South India

Theophilus Lakiang  1 , N Sreekumaran Nair  1 , Aarthy Ramaswamy  1 , Umang Singhal  1
Affiliations

Economic impact of chronic obstructive pulmonary disease: A cross-sectional study at teaching hospital in South India

Theophilus Lakiang et al. J Family Med Prim Care. 2018 Sep-Oct.

Abstract

Background: Chronic obstructive pulmonary disease continues to be the important contribution toward disability, death, and burden in the costs of health care globally. Economic impact of COPD is attributed with substantial direct and indirect costs. COPD affects the productivity of work that poses a burden on the employers and also on individuals in terms of loss of pay, limitation of activities, and related disability.

Materials and methods: Hospital-based cross-sectional study among 24 respondents in selected hospital in Udupi Taluk. Respondents were identified by purposive sampling technique and data were collected in respondent's mother tongue. An interviewer administered questionnaire was used to collect data related to patient's demographic status, disease history, and direct and indirect costs of COPD. Data were analyzed using SPSS software version 15.

Results: The mean total direct medical cost that was observed among 24 respondents was Rs. 29,885 ± 11,995.33 and the mean total direct nonmedical cost was Rs. 7,441.25 ± 2,228.90. The mean total direct medical costs of COPD patients with comorbidity were Rs. 28,148.2353 ± 2,578.01580 and for those without comorbid illness was Rs. 13,460.0000 ± 1,255.33528. The observed mean absenteeism in the past 28 days was 193.50 ± 33.62 h. The mean absolute presenteeism of respondents is 72.05 ± 7.55.

Conclusions: The major drivers of the total cost were cost of hospitalizations and medication costs. Acknowledging the costs and economic impact of COPD is therefore extremely important in the management of COPD and in reducing the mortality and morbidity related to COPD and in improving adherence to treatment.

Keywords: Chronic obstructive pulmonary disease; cross-sectional study; economic impact.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Distribution of co-morbidity, hospitalization history, and medication history
Figure 2
Figure 2
Scatter plot depicting correlation between duration of illness and direct medical costs
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Goldcopd.Org. Global initiatives for Chronic Obstructive Lung Disease, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Inc. c2014. [Last accessed on 2014 Dec 17]. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf .
    1. WHO. Chronic Obstructive Pulmonary Disease. WHO; 2014. [Last retrieved on 2014 Dec 17]. Available from: http://www.who.int/mediacenter/factsheets/fs315/en/
    1. Punekar YS, Shukla A, Müllerova H. COPD management costs according to the frequency of COPD exacerbations in UK primary care. Int J Chron Obstruct Pulmon Dis. 2014;9:65–73. - PMC - PubMed
    1. Di Bonaventura M, Paulose-Ram R, Su J, McDonald M, Zou KH, Wagner JS, et al. The burden of Chronic Obstructive Pulmonary Disease among employed adults. Int J Chron Obstruct Pulmon Dis. 2012;7:211–9. - PMC - PubMed
    1. Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. Acute exacerbations of COPD in the United States: Inpatient burden and predictors of costs and mortality. COPD. 2012;9:131–41. - PubMed